MintNeuro Raises $5M Seed Led by Odyssey Ventures to Scale Purpose-Built Chips for Neural Devices

MintNeuro Closes $5M Seed Round

MintNeuro, a London-based semiconductor company and Imperial College London spinout, has raised $5 million in seed funding. The round was led by Odyssey Ventures, with participation from Empirical Ventures, Alumni Ventures, Jumpspace Ventures, 33East, and JSK Investments.

What the Company Does

MintNeuro builds purpose-built chips for neural devices, spanning implants through wearables. Its modular chip platform provides three core capabilities:

• Neural sensing
• Signal processing
• Stimulation

Together, these functions are designed to enable smaller, lower-power neural devices. Lower power consumption and reduced physical footprint are central constraints in implantable and wearable neurotechnology, where device size and battery life directly affect clinical viability and patient experience.

The company targets conditions including Parkinson's disease, epilepsy, and depression — neurological and psychiatric indications where neural sensing and stimulation are established or emerging therapeutic approaches.

Commercial Traction

MintNeuro has already delivered working silicon to partners, including Motif Neurotech and Amber Therapeutics. It also holds a multi-year commercial chip supply agreement with Motif Neurotech.

That combination — shipped silicon plus a multi-year supply agreement — distinguishes MintNeuro from earlier-stage chip concepts. Delivering working silicon to device partners is a meaningful validation step for a semiconductor startup, since it demonstrates that the platform can be integrated into real neural device programs rather than remaining at the design stage.

The Spinout Context

As an Imperial College London spinout, MintNeuro draws on the university's research environment. The company is headquartered in London and operates at the intersection of semiconductor design and neurotechnology — a capital-intensive combination that typically requires patient, specialized investors.

The Round

• Round type: Seed
• Amount: $5,000,000 USD
• Lead investor: Odyssey Ventures
• Participating investors: Empirical Ventures, Alumni Ventures, Jumpspace Ventures, 33East, JSK Investments
• Company headquarters: London

The seed funding follows the company's delivery of working silicon to partners and its multi-year supply agreement with Motif Neurotech.

Acquisition Perspective

MintNeuro sits in a strategically valuable position: it supplies a component layer that multiple neural device developers depend on. For acquirers in semiconductors, medical devices, or neurotechnology, a modular chip platform with existing partner integrations and a commercial supply agreement offers a route into the neural device supply chain rather than a single-product bet. The breadth of the platform — sensing, processing, and stimulation in one modular architecture — is relevant to any acquirer looking to serve implant and wearable developers across multiple clinical indications, including Parkinson's disease, epilepsy, and depression.